Loading clinical trials...
Loading clinical trials...
CAN-AIM to PREVENT: CANadian Study, Assessing Inflammatory Markers to PRedict EVents in Nephrology sTudy
Conditions
Start Date
April 1, 2010
Primary Completion Date
April 1, 2016
Completion Date
July 1, 2017
Last Updated
September 1, 2017
NCT07241390
NCT06926660
NCT06717698
NCT07450820
NCT04592640
NCT06306963
Lead Sponsor
Institute of Kidney Lifescience Technologies
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions